We provide compelling evidence that Cdk12 is a tumor suppressor gene and demonstrate its loss promotes androgen receptor (AR) and MYC-mediated hypertranscription, transcription-replication conflicts (TRCs), and resultant DNA damage. The gene discussed is CDK12; the disease is neoplasm.